Is Ardent Health Stock a Buy After a Director Purchased More Than 11,000 Shares?

Ardent Health director Robert DeMichiei purchased 11,260 shares on June 5, 2026, for approximately $98,000 at $8.73 per share, increasing his holdings by 46%. This marks the first open-market insider buy in a year for the hospital operator, with the CFO also purchasing shares the same day. The purchases signal insider confidence despite the stock's 27.51% decline over the past year.

06/12/2026, 1:15 PM • The Motley Fool

ARDENT HEALTH FINAL DEADLINE ALERT: Bragar Eagel & Squire, P.C. Urgently Reminds Ardent Health, Inc. Stockholders to Contact the Firm Before March 9th Regarding Their Rights

A class action lawsuit has been filed against Ardent Health, Inc. for allegedly reporting inflated accounts receivable and delaying loss recognition on uncollectable accounts during the class period of July 18, 2024 to November 12, 2025. The company revealed a $43 million revenue decrease in Q3 2025 after transitioning to a new accounting system, causing the stock to plummet 34% from $14.05 to $9.30 per share. Investors have until March 9, 2026 to apply as lead plaintiff.

03/08/2026, 5:24 PM • GlobeNewswire

Bronstein, Gewirtz & Grossman LLC Urges Ardent Health, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

A class action lawsuit has been filed against Ardent Health, Inc. alleging that the company made materially false and misleading statements regarding its Q3 2025 revenue and 2025 EBITDA guidance. The complaint claims revenue was overstated due to inadequate accounts receivable assessments following a new accounting system implementation, and EBITDA guidance was overstated by approximately $57.5 million (9.6%) due to industry-wide cost pressures and payer denials. Investors who purchased Ardent securities between July 18, 2024 and November 12, 2025 are encouraged to join the lawsuit.

03/08/2026, 12:00 PM • GlobeNewswire

EDR IMPORTANT DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Endeavor Group Holdings, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important March 18 Deadline in Securities Class Action - EDR

Rosen Law Firm is notifying investors in Endeavor Group Holdings (EDR), Ardent Health (ARDT), and BellRing Brands (BRBR) of upcoming lead plaintiff deadlines in securities class action lawsuits. The lawsuits allege false and misleading statements regarding share valuations, executive compensation disclosures, and conflicts of interest in merger-related filings.

03/08/2026, 10:41 AM • GlobeNewswire

ARDT FINAL DEADLINE: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Ardent Health, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important March 9 Deadline in Securities Class Action - ARDT

A securities class action lawsuit has been filed against Ardent Health, Inc. for alleged misrepresentations regarding accounts receivable accounting practices and insufficient professional malpractice liability insurance. The lawsuit claims defendants misled investors about their accounts receivable monitoring processes and used a 180-day cliff accounting method to delay recognizing uncollectible accounts. Investors with losses exceeding $100K are encouraged to join the class action before the March 9, 2026 lead plaintiff deadline.

03/08/2026, 10:11 AM • GlobeNewswire

BRBR IMPORTANT DEADLINE: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages BellRing Brands, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - BRBR

Rosen Law Firm is encouraging investors with significant losses to join multiple securities class action lawsuits. BellRing Brands faces allegations that reported sales growth was driven by customer inventory stockpiling rather than genuine consumer demand, with the company downplaying competitive pressures. The lead plaintiff deadline for BellRing is March 23, 2026.

03/08/2026, 10:11 AM • GlobeNewswire

$ARDT Class Reminder: Ardent Health Investors Reminded of the Monday March 9 Securities Class Action Deadline – Investors with Losses Urged to Contact BFA Law

BFA Law has filed a securities class action lawsuit against Ardent Health, Inc. (NYSE: ARDT) alleging the company misrepresented its receivables collection practices and delayed recognition of uncollectable accounts. The lawsuit was triggered by a 33% stock drop on November 13, 2025, following Ardent Health's disclosure of a $43 million revenue decrease and $54 million increase in professional liability reserves. Investors have until March 9, 2026, to request lead plaintiff status.

03/07/2026, 6:18 AM • GlobeNewswire

$DRVN Investigation News: Driven Brands Investors Notified of the Ongoing Securities Investigation – Investors with Losses Urged to Contact BFA Law

Bleichmar Fonti & Auld LLP is investigating Driven Brands Holdings Inc. (NASDAQ: DRVN) for potential securities fraud following a 30% stock decline on February 25, 2026. The company announced it would restate financial statements from 2023-2025 due to material accounting errors including lease accounting mistakes, cash reconciliation issues, and inappropriate revenue recognition. Material weaknesses in internal controls were also identified.

03/07/2026, 6:17 AM • GlobeNewswire

Investors who lost money on Ardent Health, Inc. (ARDT) should contact The Gross Law Firm about pending Class Action - ARDT

The Gross Law Firm has filed class action lawsuits against Ardent Health, Inc. (ARDT), Kyndryl Holdings, Inc. (KD), and Ramaco Resources, Inc. (METC) for alleged securities law violations. Ardent Health is accused of misrepresenting its accounts receivable collection practices and maintaining insufficient professional liability insurance. Investors who purchased shares during specified class periods are encouraged to register as potential lead plaintiffs by the respective deadlines.

03/06/2026, 4:00 PM • GlobeNewswire

ARDT Investors Have Opportunity to Lead Ardent Health, Inc. Securities Fraud Lawsuit with the Schall Law Firm

The Schall Law Firm is seeking investors who purchased Ardent Health, Inc. (NYSE: ARDT) securities between July 18, 2024 and November 12, 2025 to join a class action lawsuit. The company allegedly made false and misleading statements regarding accounts receivable collection practices and failed to maintain adequate professional malpractice liability insurance. Investors who suffered losses are encouraged to contact the firm before March 9, 2026.

03/04/2026, 10:07 PM • GlobeNewswire

DEADLINE ALERT for VRNS, ARDT, CRWV, BBWI: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions

Law Offices of Howard G. Smith has announced securities fraud class action lawsuits against four publicly-traded companies: Varonis Systems, Ardent Health, CoreWeave, and Bath & Body Works. The lawsuits allege that defendants made false or misleading statements regarding business operations, financial performance, and risk disclosures. Investors have until mid-March 2026 to file lead plaintiff motions.

03/04/2026, 12:00 PM • GlobeNewswire

Bronstein, Gewirtz & Grossman LLC Urges Ardent Health, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

A class action lawsuit has been filed against Ardent Health, Inc. alleging that the company made materially false and misleading statements regarding its Q3 2025 revenue and 2025 EBITDA guidance. The complaint claims revenue was overstated due to inadequate accounts receivable assessments following a new accounting system implementation, and EBITDA guidance was overstated by approximately $57.5 million due to industry-wide cost pressures and payer denials. Investors who purchased Ardent securities between July 18, 2024 and November 12, 2025 are encouraged to join the lawsuit.

03/04/2026, 12:00 PM • GlobeNewswire

Ardent Health Corporation Securities Fraud Class Action Result of Undisclosed Collections Problems and 33% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

Ardent Health faces a securities class action lawsuit for failing to disclose material information about collections problems and revenue issues. The company revealed a $43 million revenue decrease and $57.5 million EBITDA guidance cut on November 12, 2025, triggering a 34% stock price decline. Investors have until March 9, 2026 to file lead plaintiff applications.

03/03/2026, 9:35 PM • GlobeNewswire

ARDENT HEALTH URGENT DEADLINE: Bragar Eagel & Squire, P.C. Reminds Ardent Health, Inc. Stockholders to Contact the Firm Before March 9th Regarding Their Rights

A class action lawsuit has been filed against Ardent Health, Inc. for allegedly overstating accounts receivable and delaying recognition of uncollectable accounts during the period from July 18, 2024 to November 12, 2025. The company revealed a $43 million revenue decrease in Q3 2025 after transitioning to a new accounting system, causing the stock to plummet 34% from $14.05 to $9.30 per share. Investors have until March 9, 2026 to apply as lead plaintiff.

03/02/2026, 9:23 PM • GlobeNewswire

ARDT IMPORTANT DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages Ardent Health, Inc. Investors to Secure Counsel Before Important March 9 Deadline in Securities Class Action - ARDT

Rosen Law Firm has filed securities class action lawsuits against Ardent Health, Inc. and other companies for alleged misrepresentations. Ardent Health is accused of misrepresenting its accounts receivable collection processes and understating professional malpractice liability insurance reserves. Investors who purchased securities during specified class periods may be eligible for compensation, with a March 9, 2026 deadline to serve as lead plaintiff.

03/02/2026, 5:31 PM • GlobeNewswire